Evidence map›Paper›PMID 35309844›Full record

Trial reportComputational and mathematical methods in medicine2022

Evaluation of Therapeutic Effect and Prognosis of Danzhi Xiaoyao Powder Combined with Photodynamic Therapy in the Treatment of Rose Acne.

Xinjian Yu, Ni Zhang, Jing Jin, Xuwen Yin, Jing Luo

RetractedOpen access · hybridAbstract readRandomized Controlled TrialRetracted Publication
In one paragraph

Trial report in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xinjian YuHubei Provincial Hospital of Traditional Chinese Medicine, Dermatological Department, Attending Psychiatrist, 430061, China.
Ni ZhangHubei Provincial Hospital of Traditional Chinese Medicine, Dermatological Department, Supervising Technician, 430061, China.
Jing JinHubei Provincial Hospital of Traditional Chinese Medicine, Dermatological Department, Attending Psychiatrist, 430061, China.
Xuwen YinHubei Provincial Hospital of Traditional Chinese Medicine, Dermatological Department, Attending Psychiatrist, 430061, China.
Jing LuoHubei Provincial Hospital of Traditional Chinese Medicine, Dermatological Department, Attending Psychiatrist, 430061, China.ORCID https://orcid.org/0000-0002-1674-5627
Hubei Provincial Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rose acne is a chronic inflammatory skin disease that can cause paroxysmal flushing, persistent erythema, papules or papules on the face, and pustules, and it has a greater impact on the life of patients, so it is important to treat it. Objective: To investigate the effect of Danzhi Xiaoyao Powder combined with photodynamic therapy (PDT) on the curative effect evaluation and prognosis of patients with rose acne. Results: The comparison of the clinical symptom scores of the two groups of patients before treatment was not statistically significant ( Conclusion: Danzhi Xiaoyao Powder combined with PDT to treat rose acne is effective, can quickly control inflammatory papules and inflammatory erythema, effectively improve the clinical symptoms of patients, and reduce adverse reactions.

Indexed as

PhotochemotherapyPhytotherapyAdolescentAdultCombined Modality TherapyComputational BiologyDrugs, Chinese HerbalFemaleHumansMaleMiddle AgedPowdersPrognosisRetrospective StudiesRosaceaTreatment Outcomedanzhi xiaoyaoDrugs, Chinese HerbalPowders

Identifiers

PMID35309844
PMCPMC8933099
OpenAlexW4221061034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.